Aghion Daniel 4
4 · ORAMED PHARMACEUTICALS INC. · Filed Jan 30, 2024
Insider Transaction Report
Form 4
Aghion Daniel
Director
Transactions
- Award
Common Stock
2024-01-30+3,750→ 38,820 total
Footnotes (1)
- [F1]Represents Restricted Stock Units ("RSUs") that will vest in quarterly installments of approximately 937 on April 1, 2024, July 1, 2024, October 1, 2024 and January 1, 2025. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.